AXOVANT SCIENCES LTD's ticker is AXGTXXXX and the CUSIP is G0750W104. A total of 109 filers reported holding AXOVANT SCIENCES LTD in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $207,000 | +7.3% | 85,414 | 0.0% | 0.00% | – |
| Q2 2018 | $193,000 | -74.1% | 85,414 | -84.7% | 0.00% | – |
| Q1 2018 | $744,000 | -75.2% | 557,903 | -2.1% | 0.00% | – |
| Q4 2017 | $3,004,000 | -22.5% | 570,043 | +1.1% | 0.00% | – |
| Q3 2017 | $3,878,000 | -69.4% | 563,580 | +3.0% | 0.00% | -100.0% |
| Q2 2017 | $12,682,000 | +137.1% | 546,920 | +52.8% | 0.00% | – |
| Q1 2017 | $5,348,000 | +21.8% | 357,975 | +1.3% | 0.00% | – |
| Q4 2016 | $4,391,000 | -2.3% | 353,401 | +10.0% | 0.00% | – |
| Q3 2016 | $4,495,000 | +14.3% | 321,237 | +4.9% | 0.00% | – |
| Q2 2016 | $3,932,000 | +63.2% | 306,208 | +45.8% | 0.00% | – |
| Q1 2016 | $2,409,000 | -28.0% | 209,965 | +13.1% | 0.00% | – |
| Q4 2015 | $3,347,000 | +75.1% | 185,640 | +25.5% | 0.00% | – |
| Q3 2015 | $1,912,000 | – | 147,967 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 75,000,000 | $969,000,000 | 33.20% |
| RA Capital Management | 5,000,000 | $64,600,000 | 9.28% |
| Avoro Capital Advisors LLC | 406,470 | $5,252,000 | 1.36% |
| ACUTA CAPITAL PARTNERS, LLC | 140,000 | $1,809,000 | 1.05% |
| Visium Asset Management, LP | 5,159,160 | $66,656,000 | 0.91% |
| DELTEC ASSET MANAGEMENT LLC | 162,417 | $2,098,000 | 0.52% |
| Atika Capital Management LLC | 75,000 | $969,000 | 0.48% |
| Perceptive Advisors | 820,000 | $10,594,000 | 0.42% |
| Vident Investment Advisory, LLC | 167,551 | $2,165,000 | 0.30% |
| Foresite Capital Management II, LLC | 65,000 | $840,000 | 0.26% |